Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
Abroad (travel likely)RecruitingPHASE1
Conditions
Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Michigan, Ann Arbor, Michigan, United States
Contact: Study coordinator (Cancer Cancer Answer Line) · CancerAnswerLine@med.umich.edu · 800-865-1125University of Michigan Health West, Wyoming, Michigan, United States
Contact: Principal Investigator (Chester Wilson, MD)UHCMC Seidman Cancer Center, Cleveland, Ohio, United States
Contact: Principal Investigator (Janice Lyons, MD)
Study leads
Erin Cobain, MD
Principal Investigator
University of Michigan Rogel Cancer Center
Corey Speers, MD, PhD
Principal Investigator
University of Alabama at Birmingham